Stockscreener 앱 받기
3.98
9.34%
-0.41
시간 외 거래:
3.92
-0.06
-1.51%
전일 마감가:
$4.39
열려 있는:
$4.11
하루 거래량:
48,449
Relative Volume:
0.11
시가총액:
$8.71M
수익:
-
순이익/손실:
$-7.77M
주가수익비율:
-0.4018
EPS:
-9.9046
순현금흐름:
$-6.52M
1주 성능:
+0.00%
1개월 성능:
+50.19%
6개월 성능:
+39.65%
1년 성능:
-59.65%
1일 변동 폭
$3.98
$4.37
1주일 범위
$3.89
$4.64
52주 변동 폭
$1.31
$10.75
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
명칭
Adial Pharmaceuticals Inc
전화
434-422-9800
주소
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Compare ADIL vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
3.98 | 9.43M | 0 | -7.77M | -6.52M | -9.9046 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-14 | 개시 | Rodman & Renshaw | Buy |
| 2018-10-30 | 개시 | Maxim Group | Buy |
| 2018-10-11 | 개시 | Dawson James | Buy |
Adial Pharmaceuticals Inc 주식(ADIL)의 최신 뉴스
Adial Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Adial Pharmaceuticals (NASDAQ: ADIL) lifts cash to $28.7M but flags going‑concern risk - Stock Titan
Form 8K Adial Pharmaceuticals Inc For: 13 August By Investing.com - Investing.com Nigeria
Adial Pharmaceuticals plans leadership changes tied to annual meeting vote - Investing.com
Adial Pharmaceuticals Plans Major Leadership and Board Transition - TipRanks
Adial PharmaceuticalsAs Of Aug 10, Anticipates Termination Of CEO Cary Claiborne After 2026 Annual Meeting - TradingView
Adial Pharmaceuticals Inc (ADIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Adial Pharmaceuticals Acquires Azora Therapeutics in Stock-and-Preferred Deal - Minichart
Adial Pharmaceuticals announces annual shareholder meeting - Bitget
Form 8K Adial Pharmaceuticals Inc For: 11 August By Investing.com - Investing.com Canada
Adial Pharmaceuticals (NASDAQ: ADIL) outlines Azora merger, heavy dilution and $53M share overhang - Stock Titan
Adial Pharmaceuticals Inc expected to post a loss of $1.03 a shareEarnings Preview - TradingView
Adial Pharmaceuticals Price Target Announced at $11.00/Share by Alliance Global Partners - Moomoo
Adial Pharmaceuticals Initiated at Buy by Alliance Global Partners - moomoo.com
A. G. P. Initiates Adial Pharmaceuticals(ADIL.US) With Buy Rating, Announces Target Price $11 - moomoo.com
Adial Pharmaceuticals Inc (ADIL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Adial Pharmaceuticals Inc (ADIL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Adial Pharmaceuticals Inc (ADIL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Adial Pharmaceuticals Inc (ADIL) Institutional Confidence - TradingKey
Adial Pharmaceuticals Inc (ADIL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ADIL|Adial Pharmaceuticals Inc|Price:2.860|Chg%:+0.080 - TradingKey
Adial Pharmaceuticals Inc (ADIL) Cash Flow - tradingkey.com
ADIL|Adial Pharmaceuticals Inc|Price:4.400|Chg%:+0.090 - TradingKey
Adial Pharmaceuticals, Inc Revenue Breakdown – NASDAQ:ADIL - TradingView
Adial Pharmaceuticals (ADIL) Slides 1.09% as Stock Tests Key Support ZoneExhaustion Gap - dars.gov.et
Adial Pharmaceuticals (ADIL) Edges Higher as Shares Test Key Resistance ZoneVolume Profile - dars.gov.et
Adial Pharmaceuticals (ADIL) Slides 3.57%: Testing Key Support Near $2.56Accumulation Line - dars.gov.et
Form 4 Adial Pharmaceuticals Inc For: 16 July By Investing.com - Investing.com South Africa
Coastlands Capital buys $8,690 of Adial Pharmaceuticals stock By Investing.com - Investing.com Nigeria
Coastlands Capital buys $8,690 of Adial Pharmaceuticals stock - Investing.com
Coastlands Capital (NASDAQ: ADIL) buys 3,233 ADIAL shares in open market - Stock Titan
Adial Pharmaceuticals (ADIL) Edges Higher on Potential Breakout Above Key ResistanceInside Day Breakout - dars.gov.et
Adial Pharmaceuticals ADIL Edges Higher on Potential Breakout Above Key ResistanceMarket Intelligence - po-news-eg.net
Form 4 Adial Pharmaceuticals Inc For: 13 July By Investing.com - Investing.com Nigeria
10% owner Coastlands Capital buys $32,637 in Adial Pharmaceuticals By Investing.com - Investing.com Nigeria
10% owner Coastlands Capital buys $32,637 in Adial Pharmaceuticals - Investing.com
Coastlands Capital LP (NASDAQ: ADIL) reports new insider share purchases - Stock Titan
Adial Pharmaceuticals (ADIL) Stock Forecast & Analyst Ratings - Moomoo
Adial Pharmaceuticals (ADIL) Hovers Near Support as Biotech Sector Faces PressureRating Change - Bölüm Sonu Canavarı
Price to earnings forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Adial Pharmaceuticals Inc (ADIL) Reclaims Ground: Up 3.20% to $2.9Wave Extension - dars.gov.et
Price to sales forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Coastlands Group takes 14.22% position in Adial Pharmaceuticals (ADIL) - Stock Titan
Enterprise value to EBIT forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Coastlands Capital LP acquires $65,000 in Adial Pharmaceuticals By Investing.com - Investing.com Nigeria
Coastlands Capital LP acquires $65,000 in Adial Pharmaceuticals - Investing.com
Form 4 Adial Pharmaceuticals Inc For: 1 July By Investing.com - Investing.com Canada
Adial Pharmaceuticals (ADIL) holder Coastlands Capital adds 25,000 shares - Stock Titan
Price to book forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Enterprise value to revenue forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Adial Pharmaceuticals (ADIL) Gains 1.17% as Shares Approach Key Resistance LevelMFI Oversold - dars.gov.et
Adial Pharmaceuticals Inc (ADIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.07%
자본화:
|
볼륨(24시간):